Webinar On-Demand: Shift the Paradigm to Centrifuge-less Immuno-staining of Cells for Superior Viability, Recovery & Data
Automated cell preparation by Laminar Wash yields cleaner and clearer data for flow cytometry
Fast, reproducible results with increased cell retention and viability leads to superior data quality
See examples of enhanced cell retention, improved reproducibility and time savings
Publications and other useful links
Laminar Wash technology is for scientists who believe that quantitative flow cytometry is critical to cell therapy, immuno-oncology, and other fields where cell analysis is important.
Flow cytometry depends on data consistency and reproducibility to yield biologically relevant information. Yet traditional sample prep methods often fail to deliver on these key criteria. How can we address this challenge?
By moving away from centrifugation, the traditional way of processing your cells, and automating your flow cytometry workflow, from sample preparation to data analysis using laminar washing. This process allows for standardization of sample preparation methods for various cell analysis applications.
Laminar Wash technology significantly improves debris removal, increasing the retention and viability of rare cell populations. The distinct resolution and identification of target and rare cellular populations supports the gamut of therapeutic development, from biomarker identification and discovery, to predicting cellular expansion success during manufacturing.
By eliminating centrifugation and supernatant removal steps (e.g., aspirating and flicking), Laminar Wash reduces sample handling and hands-on time, freeing your lab to take on more challenging endeavors.
If you’re interested in obtaining the most reproducible data among users and locations, then Laminar Wash technology is for you.
TRADITIONAL
WORKFLOW
VS
LAMINAR FLOW
TECHNOLOGY
Scientific Data
Laminar Wash Improves Gating of Live Cells
Laminar Wash Reduces Operator Variability.
After adopting the Laminar Wash technology users experienced low CVs in populations between operators and between experimental days.
EuroFlow consists of 20 expert academic research centers and one industry group in the fields of flow cytometry and molecular diagnostics. Their aim is to create protocols that will standardize quantitative flow cytometry for diagnostic applications. Their website presents several published protocols and other useful references, which you can access at the link below.
This United States government organization has a program on quantitative flow cytometry measurements that develops reference materials, methodology, and procedures enabling quantitative measurements on cells. Curiox joined this consortium in September of 2021 to support standardization in cell and gene therapy manufacturing.